On February 14, 2025, Ono Pharmaceuticals secured FDA approval for vimseltinib, a therapy for tenosynovial giant cell tumor (TGCT), which will be marketed as ROMVIMZA. This approval places Ono in direct competition with another Japanese […]
Tag: DelveInsight Business Research
Global High Potency Active Pharmaceutical Ingredients Market to Surpass USD 45 Billion Mark by 2032
The high-potency active pharmaceutical ingredients market is growing rapidly, driven mainly by the increasing global burden of chronic diseases. Key factors contributing to this expansion include the rising prevalence of cancer and diabetes, greater government […]
Global Influenza Vaccine Market is Projected to Cross USD 14 Billion Mark by 2032
The growing global prevalence of influenza, mainly due to the transmission of the virus through droplets from coughing and sneezing, is the primary driver for the need for influenza vaccination. The market growth is largely […]
Global Transmucosal Drugs Market to Reach ~USD 28 Billion by 2032
The increasing prevalence of chronic conditions like cardiovascular disease is driving the demand for transmucosal drugs. Key factors contributing to the transmucosal drugs market’s growth from 2025 to 2032 include the rising adoption of these […]
Multiple System Atrophy Market Set to Experience Significant Growth with Breakthrough Therapies by 2034
The dynamics of the multiple system atrophy treatment market is anticipated to change during the forecast period as companies across the 7MM are diligently working towards the development of novel treatment options to combat the […]
